~~<i id='757914C551'><strike id='757914C551'><tt id='757914C551'><pre id='757914C551'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：leisure time 2025-09-27 19:06:16 Page View：8

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: New research from Sanofi, Regeneron, etc.
Next article： Wildfire smoke exposes gaps in outdoor worker protections

comprehensive

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

Health and fitness trackers are measuring the wrong things

BebetoMatthews/APTurnonyourTVoropenawebbrowserthisJanuary,andyou’llbebombardedwithadsforfitnesstrack

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

First Opinion Podcast: How to protect health care in times of war

Injusttwoweeks,thebrutalityoftheIsrael-Hamasconflicthasshockedtheworld.Butoneofitsmostheartbreakinga